Immune thrombocytopenia (ITP) trials in Denmark
3 of 3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- Where
- Odense C
- Age
- 18 years to 64 years
- People
- 68 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06721013 · EU 2024-518502-40-00 - Phase 2Not yet taking people in DenmarkStudy of Zola-cel (BMS-986353), CD19 NEX-T CAR T Cells in Autoimmune Cytopenia (Breakfree-AiCE)
- Where
- Odense C
- Age
- 18 years and over
- People
- 3 worldwide
- Run by
- Celgene Corp.
See details and how to join2025-524993-41-00 - Phase 2Not yet taking people in DenmarkStudy of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)
- Where
- Odense
- Age
- 18 years and over
- People
- 52 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07603557